 | |||||
| lose weight | |||||
| NEWS | |||||
| GLP-1 Receptor Agonists Tied to Risks and Benefits Beyond Weight Loss For people with diabetes, the use of GLP-1 RAs is associated with a reduced risk for certain disorders and conditions, including neurocognitive ...
| |||||
| Ozempic and Wegovy surge to national approval with most U.S. adults considering it 'a good ... When it comes to ages 12 to 18 who are dealing with obesity, Americans are divided: About one-third say the use of weight-loss drugs in this context ...
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
